Expedited Call for Comments
Deadline: 11pm EST Sunday, November 29
Per ISPE's 1.7.5 Expedited Policy Process (see Policy Manual here), the ISPE Executive Committee has authorized the expedited policy review of comments prepared by ISPE's RWE Task Force in response to the UK's MHRA draft guidance on randomised controlled trials generating real-world evidence to support regulatory decisions.

The deadline for member comments to the RWE Task Force paper is 11:00 pm US Eastern time on Sunday, November 29th. The comment period cannot be extended. Upon completing the review period, the authors will be provided submitted comments and, if required, prepare an updated paper for Board endorsement. The final paper will be posted to the ISPE website and shared with members.
Click the title above, or the button below, to open the document for comments.
ISPE uses Adobe Creative Cloud for commenting. Sign-in if you have an Adobe account, or continue as a Guest.

To comment, highlight the word, sentence, or section you would like to comment on and enter your comments in the box that appears on the right-hand side. You can also add sticky notes to the document using the sticky note icon from the toolbar.

If you have questions on Adobe's comment features, you can visit their help center online, or you can email us at shannon@pharmacoepi.org.
ISPE
4800 Hampden Ln Ste 200
Bethesda, MD 20814
www.pharmacoepi.org